← SynDRA
IMARADENANT
SynDRA canonical compound SYN0040067 — structure-anchored drug synonym record
| Clinical phase | Phase 1/Phase 2 |
|---|
| Primary target(s) | ADORA2A |
|---|
| Mechanism of action | adenosine receptor antagonist |
|---|
All known targets
Mechanisms of action (all sources)
- ADORA2A ANTAGONIST
- Adenosine A2a receptor antagonist
- ADORA1 ANTAGONIST
- ADORA2B ANTAGONIST
- adenosine receptor antagonist
Cross-references
Synonyms
- AZD-4635
- AZD4635
- AZD-4635 (HTL1071)
- HTL-1071
- HTL1071
- IMARADENANT (AZD4635)
- NCWQLHHDGDXIJN-UHFFFAOYSA-N
- 6-(2-chloro-6-methylpyridin-4-yl)-5-(4-fluorophenyl)-1,2,4-triazin-3-amine
- SCHEMBL2320714
- EX-A1681
- AC-30333
- HY-101980
- CS-0022379
- 5-(4-fluorophenyl)-6-(2-chloro-6-methyl-pyridin-4-yl)-1,2,4-triazin-3-amine
- Imaradenant [INN]
- IMARADENANT [WHO-DD]
- AZD 4635 [WHO-DD]
- UNII-770140J08A
- RefChem:147918
- imaradenant (proposed INN)
- A2AR Antagonist AZD4635
- Adenosine A2A Receptor Antagonist AZD4635
- MFCD31618022
- Imaradenant (AZD4635)
- orb1303008
- SCHEMBL29353551
- GTPL11153
- BDBM493757
- GLXC-10911
- AZD4635?
- NSC802101
- US10988455, Example 1(xcv)
- AKOS037515559
- EBC-415057
- NSC-802101
- NCGC00537541-04
- BA166803
- BS-15183
- SY235759
Look up IMARADENANT in the interactive SynDRA portal →